Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies

COVID-19 is caused by SARS-CoV-2 which is a new enveloped virus that belongs to the Beta coronavirus genus. As a major health crisis, SARS-CoV-2 has infected over a million people around the world. There is currently no specific treatment available for patients with COVID-19 infection. Numerous pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Liu, Shanglong, Zhang, Shuchao, Ju, Qiang, Zhang, Shaoqiang, Yang, Yuanming, Wang, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834275/
https://www.ncbi.nlm.nih.gov/pubmed/32561113
http://dx.doi.org/10.1016/j.transci.2020.102839
_version_ 1783642246680150016
author Li, Ying
Liu, Shanglong
Zhang, Shuchao
Ju, Qiang
Zhang, Shaoqiang
Yang, Yuanming
Wang, Haiyan
author_facet Li, Ying
Liu, Shanglong
Zhang, Shuchao
Ju, Qiang
Zhang, Shaoqiang
Yang, Yuanming
Wang, Haiyan
author_sort Li, Ying
collection PubMed
description COVID-19 is caused by SARS-CoV-2 which is a new enveloped virus that belongs to the Beta coronavirus genus. As a major health crisis, SARS-CoV-2 has infected over a million people around the world. There is currently no specific treatment available for patients with COVID-19 infection. Numerous potential therapies, including supportive intervention, immunomodulatory agents, antiviral therapy, and convalescent plasma transfusion, have been used in clinical practice. Herein, we summarize the current potential therapeutic approaches for diseases related to COVID-19 infection and discusses the clinical value of blood transfusion-related technologies used in COVID-19 treatment.
format Online
Article
Text
id pubmed-7834275
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-78342752021-01-26 Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies Li, Ying Liu, Shanglong Zhang, Shuchao Ju, Qiang Zhang, Shaoqiang Yang, Yuanming Wang, Haiyan Transfus Apher Sci Review COVID-19 is caused by SARS-CoV-2 which is a new enveloped virus that belongs to the Beta coronavirus genus. As a major health crisis, SARS-CoV-2 has infected over a million people around the world. There is currently no specific treatment available for patients with COVID-19 infection. Numerous potential therapies, including supportive intervention, immunomodulatory agents, antiviral therapy, and convalescent plasma transfusion, have been used in clinical practice. Herein, we summarize the current potential therapeutic approaches for diseases related to COVID-19 infection and discusses the clinical value of blood transfusion-related technologies used in COVID-19 treatment. Elsevier Ltd. 2020-10 2020-06-03 /pmc/articles/PMC7834275/ /pubmed/32561113 http://dx.doi.org/10.1016/j.transci.2020.102839 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Li, Ying
Liu, Shanglong
Zhang, Shuchao
Ju, Qiang
Zhang, Shaoqiang
Yang, Yuanming
Wang, Haiyan
Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies
title Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies
title_full Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies
title_fullStr Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies
title_full_unstemmed Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies
title_short Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies
title_sort current treatment approaches for covid-19 and the clinical value of transfusion-related technologies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834275/
https://www.ncbi.nlm.nih.gov/pubmed/32561113
http://dx.doi.org/10.1016/j.transci.2020.102839
work_keys_str_mv AT liying currenttreatmentapproachesforcovid19andtheclinicalvalueoftransfusionrelatedtechnologies
AT liushanglong currenttreatmentapproachesforcovid19andtheclinicalvalueoftransfusionrelatedtechnologies
AT zhangshuchao currenttreatmentapproachesforcovid19andtheclinicalvalueoftransfusionrelatedtechnologies
AT juqiang currenttreatmentapproachesforcovid19andtheclinicalvalueoftransfusionrelatedtechnologies
AT zhangshaoqiang currenttreatmentapproachesforcovid19andtheclinicalvalueoftransfusionrelatedtechnologies
AT yangyuanming currenttreatmentapproachesforcovid19andtheclinicalvalueoftransfusionrelatedtechnologies
AT wanghaiyan currenttreatmentapproachesforcovid19andtheclinicalvalueoftransfusionrelatedtechnologies

Ejemplares similares